Atomoxetine Capsules, USP, 25 mg, 30 capsule bottles recall — FDA D-0240-2025
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Complete FDA and NHTSA recall records dated in February 2025.
These records include useful source details for the selected month.
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.
BMW of North America, LLC (BMW) is recalling certain 2025 X3 30 xDrive vehicles. The connection between the positive battery cable and the starter-generator may have been improperly…
BMW of North America, LLC (BMW) is recalling certain 2022-2024 X3 sDrive30i and X3 xDrive30i vehicles. The second-row seat side door locking modules may not function properly and allow the…
Retroactive-Due to increase in complaints, their is a potential for drawer and/or door failures of the medication cabinet which could result in delay in accessing medications.
Due to the lack of the Ethylene Vinyl Alcohol (EVOH) barrier layer.
Devices presented a condition in which the inner needle separated from the hub and produced a longer throw of the inner needle or dislodgement.
Potential for endotoxin contamination in non-sterile surgical strips and patties in Presource Kits.
Retroactive-Due to increase in complaints, their is a potential for drawer and/or door failures of the medication cabinet which could result in delay in accessing medications.
Potential for endotoxin contamination in non-sterile surgical strips and patties in Presource Kits.
Retroactive-Due to increase in complaints, their is a potential for drawer and/or door failures of the medication cabinet which could result in delay in accessing medications.
Potential for endotoxin contamination in non-sterile surgical strips and patties in Presource Kits.
Labeling is insufficient regarding delays in access to medication. The firm is strengthening the label as an additional risk mitigation.
Potential for endotoxin contamination in non-sterile surgical strips and patties in Presource Kits.
The MSOT Acuity Echo does not include an adequate instruction for safe operation of the device. The previous version of the user manuals contained a wrong value for the Nominal Ocular…
Due to faulty circuit board in speed control remote use in conjunction with a wheelchair power assist, their is a potential for lost of control of device potentially resulting in minor and…
Potential for endotoxin contamination in non-sterile surgical strips and patties in Presource Kits.
Due to the lack of the Ethylene Vinyl Alcohol (EVOH) barrier layer.
Sevoflurane used with the vaporizer may degrade to hydrogen fluoride, which could present a risk to patients or health care providers through inhalation and/or skin exposure. Potential…
Potential for endotoxin contamination in non-sterile surgical strips and patties in Presource Kits.
Potential for endotoxin contamination in non-sterile surgical strips and patties in Presource Kits.
Spore test strip monitoring system, designed for routine monitoring of sterilization processes, may have a printing error on the return envelope that may cause spore test results to be…
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.